Envestnet Asset Management Portfolio holdings
Envestnet Asset Management, a subsidiary of Envestnet, Inc., founded in 1999 by Jud Bergman and Bill Crager, is a Chicago-based financial technology firm that provides wealth management solutions and software to financial advisors and institutions, managing over $426 billion in discretionary assets as of late 2024. Headquartered at 35 East Wacker Drive, it serves a vast network, including over 111,000 advisors and major U.S. banks, with a platform overseeing more than $6.5 trillion in assets, offering tools like portfolio management, trading, and reporting through an integrated ecosystem. Known for its innovative AdvisorSuite software and Portfolio Management Consultants (PMC) division, Envestnet supports advisors with sub-advisory services, research, and data analytics, bolstered by its 2015 acquisition of Yodlee for enhanced data aggregation. Recently acquired by a Bain Capital-led consortium for $4.5 billion in November 2024, Envestnet continues to evolve as a private entity, focusing on scalable, tech-driven wealth management solutions.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.9B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$911M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$888M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$837M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
+$631M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$1.23B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$729M |
| 3 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$561M |
| 4 |
HDV
iShares Core High Dividend ETF
HDV
|
+$454M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.75% |
| 2 | Healthcare | 4.62% |
| 3 | Financials | 3.92% |
| 4 | Consumer Discretionary | 2.76% |
| 5 | Industrials | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Ardagh Metal Packaging
AMBP
$3.01B
| $53K | ﹤0.01% |
10,939
-862
| -7% | -$5.25K |
|
3802
Tencent Music
TME
$14.4B
| $53K | ﹤0.01% |
13,003
-19,292
| -60% | -$87.8K |
|
3803
Apyx Medical
APYX
$139M
| $52K | ﹤0.01% |
11,682
+239
| +2% | +$1.71K |
|
3804
FuelCell Energy
FCEL
$1.58B
| $50K | ﹤0.01% |
491
-57
| -10% | -$6.82K |
|
|
TUYA
3805
Tuya Inc
TUYA
$1.11B
| $50K | ﹤0.01% |
+53,470
| New | +$86.1K |
|
|
DOYU
3806
DouYu International Holdings
DOYU
$142M
| $48K | ﹤0.01% |
+4,806
| New | +$60.8K |
|
3807
ThredUp
TDUP
$410M
| $48K | ﹤0.01% |
26,343
+2,874
| +12% | +$7.21K |
|
|
ONCT
3808
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $48K | ﹤0.01% |
2,696
-55
| -2% | -$1.18K |
|
|
CANG
3809
Cango Inc
CANG
$66.9M
| $46K | ﹤0.01% |
1,988
-6,160
| -76% | -$149K |
|
3810
Fortress Biotech
FBIO
$88M
| $46K | ﹤0.01% |
3,566
+1,803
| +102% | +$27K |
|
|
SIFY
3811
Sify Technologies
SIFY
$1.1B
| $45K | ﹤0.01% |
4,390
-12,998
| -75% | -$165K |
|
3812
Viking Therapeutics
VKTX
$3.97B
| $45K | ﹤0.01% |
16,382
-1,974
| -11% | -$6.46K |
|
|
HEPA
3813
DELISTED
Hepion Pharmaceuticals
HEPA
| $44K | ﹤0.01% |
88
+28
| +47% | +$17.1K |
|
|
CGC
3814
Canopy Growth
CGC
$422M
| $42K | ﹤0.01% |
1,540
-286
| -16% | -$8.82K |
|
3815
Aveanna Healthcare
AVAH
$1.97B
| $40K | ﹤0.01% |
26,848
+405
| +2% | +$832 |
|
|
NNDM
3816
Nano Dimension
NNDM
$349M
| $40K | ﹤0.01% |
16,722
-1,564
| -9% | -$4.78K |
|
3817
Cerus
CERS
$528M
| $38K | ﹤0.01% |
10,677
-29,258
| -73% | -$140K |
|
3818
Grab
GRAB
$15.3B
| $38K | ﹤0.01% |
+14,626
| New | +$44.3K |
|
|
RNTX
3819
Rein Therapeutics
RNTX
$69.5M
| $38K | ﹤0.01% |
9,201
+3,182
| +53% | +$13.4K |
|
3820
Coeur Mining
CDE
$18.7B
| $37K | ﹤0.01% |
10,753
| – | – |
|
3821
Banco Bradesco
BBDO
$33.2B
| $36K | ﹤0.01% |
+11,925
| New | +$34.6K |
|
|
ADAM
3822
Adamas Trust
ADAM
$922M
| $36K | ﹤0.01% |
+3,800
| New | +$43.1K |
|
|
ATHE
3823
Alterity Therapeutics
ATHE
$84.6M
| $35K | ﹤0.01% |
7,807
-432
| -5% | -$2.53K |
|
3824
Outlook Therapeutics
OTLK
$206M
| $35K | ﹤0.01% |
1,428
+192
| +16% | +$4.46K |
|
|
WIMI
3825
WiMi Hologram Cloud
WIMI
$24.8M
| $35K | ﹤0.01% |
+2,302
| New | +$42.6K |
|
Similar funds
Envestnet Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Envestnet Asset Management held 4,115 positions worth $175B, down 2.1% from $179B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Envestnet Asset Management deployed $7.33B of net new capital in Q3 2022, opening 205 new positions and adding to 2,159 existing holdings. Its largest new stake was GSK: 622,292 shares worth $18.3M.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 5.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $1.23B trimmed.
- Envestnet Asset Management's largest Q3 2022 buy was GSK: 622,292 shares worth $18.3M.
- Envestnet Asset Management added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $1.9B increase.
- Envestnet Asset Management's biggest Q3 2022 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $1.23B.
- Envestnet Asset Management fully exited Atlassian in Q3 2022, selling an estimated $67.3M.
- Envestnet Asset Management's ten largest holdings make up 26% of its $175B portfolio in Q3 2022.
- Envestnet Asset Management opened 205 new positions and closed 219 in Q3 2022.
- Envestnet Asset Management's portfolio value fell 2.1% quarter-over-quarter to $175B.
Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.